Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIRT with Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma
NCT02801487Phase 2Terminated
- Sponsor
- Shanghai Proton and Heavy Ion Center
- Start
- Sep 2015
- Primary completion
- Jan 2017
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in nasopharyngeal carcinoma (NPC), sponsored by Shanghai Proton and Heavy Ion Center. Primary endpoint: Number of participants with treatment-related adverse events at 4 months. Started Sep 2015; status: terminated.
02
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02801487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02801487.